Vertex Pharmaceuticals grants director Daniel J. Brennan 795 restricted stock units
VRTX•Vertex Pharmaceuticals granted director Daniel J. Brennan 795 shares of common stock on Oct. 20, 2026.
1. Stock grant
Vertex Pharmaceuticals granted director Daniel J. Brennan 795 shares of common stock on Oct. 20, 2026.
